AGP Executive Report
Last update: an hour agoObesity Care: Pharmacists can help patients navigate coverage, costs and side effects of GLP-1 medicines. Zealand Pharma and Generate Biomedicines also announced an AI-driven partnership to develop new treatments for obesity and other metabolic diseases. Outbreak Watch: Georgia’s measles count has reached 22 this year, up from 10 in all of 2025; health officials urge vaccination. Ontario officials are also encouraging people to get eligible flu and COVID-19 shots as respiratory illness season begins. New Treatment: The FDA approved Juvmo, a once-daily pill for Parkinson’s disease, offering an alternative to medications that require more frequent dosing. Maternal Health: A study found extending Medicaid coverage to 12 months after birth increased follow-up care for women with pregnancy-related diabetes or high blood pressure. Separately, research linked opioid prescriptions during pregnancy with higher childhood hospital admission rates. Food & Wellness: A nutrition comparison finds peanuts offer more protein by weight, while pistachios provide more complete protein. Traditional Chinese Medicine practitioners may view facial changes as part of a broader assessment, but facial signs alone cannot diagnose lung disease.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[The gap between how sleep medicine is practiced and how it’s paid for]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/29379332-949369282-a066f6e4a568b8a868080ba84738b5a07bf13181-1200x800-200x133.jpeg)
